Gowling WLG advised Innocan on this transaction. Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) has successfully completed the second and final tranche of its...
Innocan Pharma Corporation’s Second and Final Tranche of its Private Placement
Innocan Pharma Corporation’s $8.2 Million Private Placement
Gowling WLG advised Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF). Innocan Pharma Corporation had closed its private placement of common shares and warrants to purchase...